Brokerages Expect Core Laboratories (NYSE:CLB) Will Post Quarterly Sales of $110.09 Million

Core Laboratories logo Wall Street analysts expect Core Laboratories (NYSE:CLB) to report sales of $110.09 million for the current fiscal quarter, according to Zacks . Three analysts have provided estimates for Core Laboratories’ earnings, with estimates ranging from $110.00 million to $110.20 million. Core Laboratories posted sales of $156.78 million during the same quarter last year, which would indicate a negative year over year growth rate of 29.8%. The company is scheduled to announce its next quarterly earnings report after the market closes on Wednesday, January 27th. According to Zacks, analysts expect that Core Laboratories will report full-year sales of $483.47 million for the current year, with estimates ranging from $483.00 million to $483.70 million. For the next year, analysts forecast that the firm will report sales of $473.40 million, with estimates ranging from $465.00 million to $489.90 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Core Laboratories. CLB has been the subject of several research reports. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell increased their target price on shares of Core Laboratories from $16.00 to $30.00 in a research note on Tuesday, December 15th. […]

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.